2017 sees Cochrane enter its fourth year of Strategy to 2020, which aims to put Cochrane evidence at the heart of health decision-making all over the world.

Cochrane’s Senior Management Team has recently released a document that provides the Governing Board, and the wider Cochrane community, with a definition of success for each of the Strategy to 2020 objectives; an assessment of predicted progress by the end of 2017; and a framework for establishing the work still to be done.

To find out more, please read a recent post on the Cochrane Community Blog which includes an interview with our CEO Mark Wilson and a link to our definitions of success document.

Defining Cochrane’s success - an interview with our CEO